http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9213859-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2b9dc89cc4ba060cc73bbf0c90bbb78
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-40
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-40
filingDate 1992-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbb171817c9f73222726f740895b3b3e
publicationDate 1992-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9213859-A1
titleOfInvention Pharmaceuticals
abstract A process for preparing 2-amino-6-chloropurine or a 2-acylated derivative thereof, comprising reacting guanine or 2,9-diacylguanine with a chlorinating agent, in the presence of methyltriethylammonium chloride as phase transfer catalyst, and thereafter when necessary, removing the 9-acyl group by hydrolysis.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100455241-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0543095-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5440037-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9621664-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0543095-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0644193-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9315075-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5391733-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5389637-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0644193-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6187921-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0590361-A1
priorityDate 1991-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9101310-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0182024-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0433846-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0141927-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0203685-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226433476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226516456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233712890
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465501246
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398748
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228546862
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226432038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136385364
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228546866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136360183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226407678
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70440
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226590413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228546869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8150
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234883100
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70296051
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67860209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136093953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60021
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141795200

Total number of triples: 60.